Toggle Main Menu Toggle Search

Open Access padlockePrints

Expression of topoisomerase IIIα in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody

Lookup NU author(s): Andrew Lodge, Dr John Anderson, Dr Beate Haugk, Dr Brian Angus


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Topoisomerases are nuclear enzymes that modulate the topological structure of DNA in order to facilitate cellular events such as replication and transcription. These enzymes are also the cellular targets of certain classes of chemotherapeutic agents termed topoisomerase poisons. A new human topoisomerase isoform, IIIα, was discovered in 1996, which is thought to have roles in genome stability and possibly chromosome separation during mitosis. It is possible that novel or existing anti-topoisomerase agents target topoisomerase IIIα, suggesting that this enzyme may have potential as a prognostic marker and chemotherapeutic target. In order to study expression patterns of topoisomerase IIIα we have produced a novel monoclonal antibody to human topoisomerase IIIα (TOPO3a-1A4), and used it to assess topoisomerase IIIα expression in a wide range of normal and neoplastic tissues. We have found that topoisomerase IIIα is expressed in a wide range of tissue types, with especially high concentrations in endothelial cells and stromal fibroblasts. No general relationship was observed between expression of topoisomerase IIIα and proliferation. Expression in neoplastic tissues often paralleled their normal counterparts, although certain tumours showed either increased (e.g. colonic adenoma) or reduced (e.g, gastric carcinoma. small cell carcinoma of bronchus) expression. If topoisomerase IIIα is found to be a target for chemotherapeutic agents, clinical response in different tumour types may be related to topoisomerase IIIα expression, which may be assessed using TOPO3a-1A4. (C) 2000 Cancer Research Campaign.

Publication metadata

Author(s): Lodge, A.J., Anderson, J.J., Ng, S.W., Fenwick, F., Steward, M., Haugk, B., Horne, C.H.W., Angus, B.

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 2000

Volume: 83

Issue: 4

Pages: 498-505

Print publication date: 01/01/2000

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827


DOI: 10.1054/bjoc.2000.1293

PubMed id: 10945498


Altmetrics provided by Altmetric